An analysis of pump thrombus events in patients in the HeartWare ADVANCE bridge to transplant and continued access protocol trial

The HeartWare left ventricular assist device (HVAD, HeartWare Inc, Framingham, MA) is the first implantable centrifugal continuous-flow pump approved for use as a bridge to transplantation. An infrequent but serious adverse event of LVAD support is thrombus ingestion or formation in the pump. In thi...

Celý popis

Uložené v:

Podrobná bibliografia
Vydané v:	The Journal of heart and lung transplantation Ročník 33; číslo 1; s. 23
Hlavní autori:	Najjar, Samer S, Slaughter, Mark S, Pagani, Francis D, Starling, Randall C, McGee, Edwin C, Eckman, Peter, Tatooles, Antone J, Moazami, Nader, Kormos, Robert L, Hathaway, David R, Najarian, Kevin B, Bhat, Geetha, Aaronson, Keith D, Boyce, Steven W
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	United States 01.01.2014
Predmet:	Adult Anticoagulants - therapeutic use Female Heart Failure - therapy Heart Transplantation Heart-Assist Devices - adverse effects Humans Incidence Kaplan-Meier Estimate Male Middle Aged Multivariate Analysis Platelet Aggregation Inhibitors - therapeutic use Retrospective Studies Survival Rate Thrombosis - epidemiology Thrombosis - mortality Thrombosis - prevention & control Treatment Outcome Ventricular Dysfunction, Left - therapy heart failure left ventricular assist device thrombus bridge to transplant HeartWare HVAD
ISSN:	1557-3117, 1557-3117
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!

Buďte prvý, kto okomentuje tento záznam!